Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-17T19:20:13.137Z Has data issue: false hasContentIssue false

Commentary

Published online by Cambridge University Press:  21 September 2006

Serge Gauthier
Affiliation:
Alzheimer's Disease Research Unit, McGill Center for Studies in Aging, Verdun, Quebec, Canada Email: [email protected]

Extract

The current debate about Mild Cognitive Impairment (MCI) is useful in bringing forward for first-line clinicians, as well as clinical researchers, the importance of paying attention to cognitive complaints in aging individuals. Clearly (and thankfully) not all will progress to dementia. Furthermore, many can be helped by primary care practitioners through a basic clinical assessment and treatment of one of the many conditions potentially associated with mild cognitive complaints, such as depression, hypothyroidism, side-effects of anticholinergic drugs, alcohol abuse, nutritional deficiency, sleep apnea. Many times the cognitive complaints will be reversible. In some cases the symptoms will persist or increase over time, and a yearly follow-up and/or a referral to a specialized setting are appropriate, since there is a higher risk of progression to dementia in such individuals, particularly towards Alzheimer's disease (AD).

Type
For Debate: Is Mild Cognitive Impairment a clinically useful concept?
Copyright
International Psychogeriatric Association 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)